Exploiting dendritic cells for cancer im
β
Karine Breckpot; Carlo Heirman; Bart Neyns; Kris Thielemans
π
Article
π
2004
π
John Wiley and Sons
π
English
β 579 KB
## Abstract Dendritic cells (DCs) are pivotal regulators of immune reactivity and immune tolerance. The observation that DCs can recruit naive T cells has invigorated cancer immunology and led to the proposal of DCs as the basis for vaccines designed for the treatment of cancer. Designing effective